| Tretinoin | Approved Investigational Nutraceutical | HDAC3 | 8841 |
downregulated | Tretinoin results in decreased expression of HDAC3 mRNA | 5q31.3 | |
| Tretinoin | Approved Investigational Nutraceutical | HDAC5 | 10014 |
upregulated | Tretinoin results in increased expression of HDAC5 mRNA | 17q21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | HDAC9 | 9734 |
downregulated | Tretinoin results in decreased expression of HDAC9 mRNA | 7p21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | HDC | 3067 |
downregulated | Tretinoin results in decreased expression of HDC mRNA | 15q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | HDDC2 | 51020 |
downregulated | Tretinoin results in decreased expression of HDDC2 mRNA | 6q22.31 | |
| Tretinoin | Approved Investigational Nutraceutical | HDHD2 | 84064 |
upregulated | Tretinoin results in increased expression of HDHD2 mRNA | 18q21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | HDLBP | 3069 |
downregulated | Tretinoin results in decreased expression of HDLBP mRNA | 2q37.3 | |
| Tretinoin | Approved Investigational Nutraceutical | HEBP2 | 23593 |
upregulated | Tretinoin results in increased expression of HEBP2 mRNA | 6q24.1 | |
| Tretinoin | Approved Investigational Nutraceutical | HECA | 51696 |
upregulated | Tretinoin results in increased expression of HECA mRNA | 6q24.1 | |
| Tretinoin | Approved Investigational Nutraceutical | HECTD2 | 143279 |
downregulated | Tretinoin results in decreased expression of HECTD2 mRNA | 10q23.32 | |
| Tretinoin | Approved Investigational Nutraceutical | HECTD4 | 283450 |
upregulated | Tretinoin results in increased expression of HECTD4 mRNA | 12q24.13 | |
| Tretinoin | Approved Investigational Nutraceutical | HERC6 | 55008 |
upregulated | Tretinoin results in increased expression of HERC6 mRNA | 4q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | HES1 | 3280 |
upregulated | Tretinoin results in increased expression of HES1 mRNA | 3q29 | |
| Tretinoin | Approved Investigational Nutraceutical | HES5 | 388585 |
downregulated | Tretinoin results in decreased expression of HES5 mRNA | 1p36.32 | |
| Tretinoin | Approved Investigational Nutraceutical | HESX1 | 8820 |
downregulated | Tretinoin results in decreased expression of HESX1 mRNA | 3p14.3 | |
| Tretinoin | Approved Investigational Nutraceutical | HEXIM1 | 10614 |
upregulated | Tretinoin results in increased expression of HEXIM1 mRNA | 17q21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | HEY1 | 23462 |
upregulated | Tretinoin results in increased expression of HEY1 mRNA | 8q21.13 | |
| Tretinoin | Approved Investigational Nutraceutical | HEY2 | 23493 |
upregulated | Tretinoin results in increased expression of HEY2 mRNA | 6q22.31 | |
| Tretinoin | Approved Investigational Nutraceutical | HGF | 3082 |
downregulated | Tretinoin results in decreased expression of HGF mRNA | 7q21.11 | |
| Tretinoin | Approved Investigational Nutraceutical | HGF | 3082 |
upregulated | Tretinoin results in increased expression of HGF mRNA | 7q21.11 | |
| Tretinoin | Approved Investigational Nutraceutical | HGSNAT | 138050 |
upregulated | Tretinoin results in increased expression of HGSNAT mRNA | 8p11.21-p11.1 | |
| Tretinoin | Approved Investigational Nutraceutical | HHEX | 3087 |
downregulated | Tretinoin results in decreased expression of HHEX mRNA | 10q23.33 | |
| Tretinoin | Approved Investigational Nutraceutical | HHEX | 3087 |
upregulated | Tretinoin results in increased expression of HHEX mRNA | 10q23.33 | |
| Tretinoin | Approved Investigational Nutraceutical | HIC1 | 3090 |
upregulated | Tretinoin results in increased expression of HIC1 mRNA | 17p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | HIKESHI | 51501 |
downregulated | Tretinoin results in decreased expression of HIKESHI mRNA | 11q14.2 | |